MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ajoc.2025.102357

Медицинская библиотека · American journal of ophthalmology case reports · 2025

Inappropriate administration of mitomycin in a cataract patient.

Merchant Gibran, DeWeerd Aaron, Mooney Jackson, Khan Manahil, Gangadhar Dasa V

Клинический случайСтатьяПеревод в очереди

Аннотация

PURPOSE: This case report describes the improper administration of intracameral mitomycin after cataract extraction in an 83-year-old male, demonstrating the need for system improvements to prevent "never events."

OBSERVATIONS: An 83-year-old male presented with visually significant bilateral cataracts, (right eye (OD): 20/80, left eye (OS): 20/70). He underwent technically uncomplicated cataract surgery in the right eye. At postoperative visit one, vision was 20/250 OD, less than anticipated for unclear reasons. On subsequent visits, the patient was found to have worsening photophobia, increasing conjunctival inflammation, corneal edema, and an elevated intraocular pressure of 27 mmHg. Given the variety and complexity of symptoms despite an otherwise uncomplicated surgery, an investigation was launched. An investigation for Toxic Anterior Segment Syndrome (TASS) revealed a mix-up between Cefuroxime and Mitomycin during medication preparation and administration. It was determined that mitomycin was inadvertently injected intracamerally into the patient's eye, causing intraocular toxicity and ultimately, loss of vision.

CONCLUSIONS AND

IMPORTANCE

This case underscores the significance of system failures in the healthcare environment and how "never events" may occur even with appropriate protocols in place. The improper administration of mitomycin emphasizes the need for enhanced safety measures, including improved medication labeling, consistent use of time-outs, and reinforcing their importance in high-volume environments. System changes are essential to reduce the risk of errors and protect patient safety. The use of off-label, compounded medications should be minimized when possible. Ophthalmologists and the pharmaceutical industry should continue to seek an FDA-approved antibiotic for intraocular use in cataract surgery.

Для цитирования: Merchant Gibran, DeWeerd Aaron, Mooney Jackson, Khan Manahil, Gangadhar Dasa V. Inappropriate administration of mitomycin in a cataract patient.. American journal of ophthalmology case reports. 2025. DOI: 10.1016/j.ajoc.2025.102357.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.